View Pages
Market Today: Moderna Tanks; WDC Reports; Lam Research Hits 6-Month Low
Moderna plunged after leaked cancer vaccine data, becoming the S&P 500’s worst performer. Lam Research fell to a six-month low amid tech selloff; Western Digital reported after-hours earnings. Market recap by Marley Kayden.
Editorial companion
What stands out
The clip highlights three simultaneous market shocks: leaked cancer-vaccine data sent Moderna (MRNA) sharply lower and made it the worst performer in the S&P 500; Lam Research (LRCX) slid to a six-month low amid broader tech selling; and Western Digital (WDC) reported earnings after the close. The juxtaposition matters because the headlines mix company-specific news (Moderna’s trial leak, WDC’s quarter) with a sector-wide tech move that amplified losses for chip-equipment and storage names.
View Pages
View Pages
Bullish Gator Snapshot
Current ratings and signals
Lam Research (LRCX)
Neutral
LRCX rates Neutral overall. The fundamental read is bullish: the company passes 8 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 20.81); revenue is growing about 11.7% per year; net income is growing about 20.2% per year. The technical picture is bearish: price is 15.0% below the 200-day moving average; 19.3% below the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is neutral (composite 56/100), based on 7 news articles and 7 qualified videos from recent coverage.
Moderna (MRNA)
Neutral
MRNA rates Neutral overall. The fundamental read is neutral: the company passes 1 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 13.60); revenue is declining about 52.3% per year. The technical picture is neutral: price is 148.0% above the 200-day moving average; 17.7% above the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is bearish (composite 24/100), based on 7 news articles, 1 TV segment, and 7 qualified videos from recent coverage.
Western Digital (WDC)
Neutral
WDC rates Neutral overall. The fundamental read is bullish: the company passes 7 of 9 quality tests on the Piotroski F-Score; balance sheet is in the Safe zone (Altman Z = 18.57); revenue is growing about 4.8% per year; net income is growing about 398.9% per year. The technical picture is bearish: price is 8.5% below the 200-day moving average; 10.8% below the 50-day; the 50/200 relationship is in a Golden cross. Sentiment is bullish (composite 74/100), based on 6 news articles and 7 qualified videos from recent coverage.